Skip to content

Comparing the effectiveness of shock wave therapy and mesotherapy

The Comparison of the effectiveness of Piroxicam mesotherapy versus Using Extracorporeal Shock Wave Therapy (ESWT) in Reducing Pain and Improving Function in Patients with rotator caff tendinopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220903055865N1
Enrollment
60
Registered
2022-10-02
Start date
2022-10-07
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Rotator cuff tendinopathy(Non-specific shoulder pain). Pain in unspecified shoulder

Interventions

Intervention 1: Intervention group: group A : Treatment of group A is to perform shock therapy session (ESWT) with frequency 10 and impulse 1000, intensity 2 to 3 based on patient tolerance, once a we

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Completing and signing the consent form Patients with shoulder pain lasting more than 4 weeks Shoulder pain with an Oxford shoulder score of at least 4 in the last month Age over 18 Absence of any type of disease around the relevant joint

Exclusion criteria

Exclusion criteria: Any pathology found on the plain radiograph, including degenerative findings of the shoulder joint Any clinical symptoms of effusion, inflammation, redness and warmth of the shoulder Having diabetes, uncontrolled blood pressure and rheumatic and vascular collagen diseases such as lupus, gout and simultaneous radiculopathy, myopathy, nerve damage and neuropathies such as carpal tunnel syndrome, stroke and any type of systemic infection. Body mass index above 42 History of joint replacement and trauma and fracture on the side of the involved shoulder Suffering from bleeding diseases and taking anticoagulant drugs Psychological problems Any hypersensitivity to drugs used in the study, such as piroxicam History of significant heart, kidney, liver, brain, lung disorders History of injections in or around the affected shoulder joint in the last 3 months History of shoulder and upper limb physiotherapy in the last one month Pregnant and lactating woman Cancer

Design outcomes

Primary

MeasureTime frame
Shoulder pain. Timepoint: Before intervention; Two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Visual analogue scale, Oxford shoulder score.

Secondary

MeasureTime frame
Patient performance. Timepoint: Before intervention; Two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Oxford shoulder scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme nazari

Shiraz University of Medical Sciences

W.faezenazari98@yahoo.com36333973

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026